OptiGel® DR Softgels / Enteric Release Innovation

Overview


Catalent’s OptiGel

Elevate your nutraceutical portfolio with patented OptiGel® DR softgel technology. Catalent’s innovative enteric release system protects sensitive ingredients and ensures targeted intestinal delivery for improved performance. Backed by deep expertise and a commitment to quality, OptiGel® DR softgels helps you meet consumer demand for effective, science-driven solutions.

This content is paid by Catalent, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Gummy supplements: Optimizing your recipe for success

Gummy supplements: Optimizing your recipe for success

In paid partnership with Catalent

Flavor, texture and color are just some of the many considerations for formulators in the evolving gummy market. Here’s how to propel your gummy offering to maximize market success.

Related Resources

Advanced Softgel Technologies for EU Self‑Care

Advanced Softgel Technologies for EU Self‑Care

Paid for by Catalent

White Paper

Discover how modern formulation strategies and advanced softgel manufacturing technologies help address common development challenges—from bioavailability considerations to navigating EU market complexity—supporting the development of reliable,...

High load creatine chews built to scale

High load creatine chews built to scale

Paid for by Catalent

Product Brochure

Performance nutrition is going mainstream, and format is a key growth lever. Catalent’s creatine soft chews are engineered to solve high dose delivery challenges with great taste, flexible dosing, and convenient formats consumers prefer.

Supplier Info Centre

Catalent.png

For more product information visit Catalent.